Differences between drug-eluting stents in patients with diabetes Clinical study 15 January 2013 Pages: 1 - 1
Influenza vaccines: brands differ in reactogenicity Epidemiology clinical study 15 January 2013 Pages: 2 - 2
Australian TGA urges caution in interpreting adverse event data News item 15 January 2013 Pages: 3 - 3
Do primary prevention benefits of statins outweigh diabetes risk? News item 15 January 2013 Pages: 3 - 3
The Danish Health and Medicines Authority intends to discuss with the EU Pharmacovigilance Working Party whether stricter measures are required News item 15 January 2013 Pages: 4 - 4
It is important to monitor pulmonary function in patients on long-term treatment with nitrofurantoin, News item 15 January 2013 Pages: 4 - 4
Sanofi Pasteur is to extend its 2-D barcoding technology to include a further six paediatric vaccines. Media release 15 January 2013 Pages: 4 - 4
The Australian Therapeutic Goods Administration (TGA) has banned the use of 1,3-dimethylamylamine (DMAA) with effect from the 8th of August 2012. News item 15 January 2013 Pages: 4 - 4
Celgene Europe Ltd. has withdrawn its application to CHMP to use lenalidomide [Revlimid] for maintenance treatment of newly diagnosed News item 15 January 2013 Pages: 4 - 4
An updated incident management plan for human medicines has been published by the EMA. News item 15 January 2013 Pages: 4 - 4
